| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2009 | CA2494528C Racemization and enantiomer separation of clopidogrel |
| 09/01/2009 | CA2490115C Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 09/01/2009 | CA2488517C Coated conditioners for use in foods and pharmaceuticals |
| 09/01/2009 | CA2477301C Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 09/01/2009 | CA2476201C Modified release formulations of at least one form of tramadol |
| 09/01/2009 | CA2467973C Pyridine derivatives as nmda receptor ligands |
| 09/01/2009 | CA2460140C Compositions for treatment of common cold |
| 09/01/2009 | CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence |
| 09/01/2009 | CA2448689C Percutaneously absorbable patches |
| 09/01/2009 | CA2438799C Preventative of therapeutic agent for inflammatory respiratory tract disease |
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/01/2009 | CA2431206C Combination drugs containing anti-sepsis cycloalkene compound |
| 09/01/2009 | CA2421761C Crab apple fruit polyphenol and production process thereof |
| 09/01/2009 | CA2420640C Combination preparations of 3-n-formyl hydroxy amino propyl phosphonic acid derivatives or 3-n-acetyl hydroxy amino propyl phosphonic acid derivatives together with special pharmaceutical active ingredients |
| 09/01/2009 | CA2417727C Fentanyl composition for nasal administration |
| 09/01/2009 | CA2417353C Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-one, and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a |
| 09/01/2009 | CA2414753C Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or [0-(2,6-dichloranilino)-phenyl]-ethanoic acid |
| 09/01/2009 | CA2403977C .gamma.-tocotrienol-containing diuretics |
| 09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
| 09/01/2009 | CA2396209C The use of mirtazapine for the treatment of sleep disorders |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/01/2009 | CA2389411C Use of egfr tyrosine kinase inhibitor for preventing breast cancer |
| 09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |
| 09/01/2009 | CA2379147C Percutaneously absorbable preparations |
| 09/01/2009 | CA2376691C Antipsychotic cyclic n-aralkylamines |
| 09/01/2009 | CA2372231C Aerosol formulations and devices for increasing libido in women via acute testosterone administration |
| 09/01/2009 | CA2370556C Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 09/01/2009 | CA2327434C Dna immunization against chlamydia infection |
| 09/01/2009 | CA2308216C Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 09/01/2009 | CA2283536C Compositions and methods for elimination of unwanted cells |
| 09/01/2009 | CA2238360C Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 09/01/2009 | CA2179728C Composition for a contraceptive comprising an estrogen and a gestagen |
| 08/27/2009 | WO2009105782A1 Hiv protease inhibitor and cytochrome p450 inhibitor combinations |
| 08/27/2009 | WO2009105781A1 Methods for inhibiting drug degradation |
| 08/27/2009 | WO2009105776A1 Diamide inhibitors of cytochrome p450 |
| 08/27/2009 | WO2009105756A2 Protection of neural retina by reduction of rod metabolism |
| 08/27/2009 | WO2009105723A2 Novel methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway |
| 08/27/2009 | WO2009105722A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105717A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105715A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | WO2009105712A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | WO2009105691A2 Uses of pentamidine and related compounds |
| 08/27/2009 | WO2009105680A2 Genetic polymorphisms associated with stroke, methods of detection and uses thereof |
| 08/27/2009 | WO2009105675A1 Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
| 08/27/2009 | WO2009105647A1 Methods for the treatment of dermatological disorders |
| 08/27/2009 | WO2009105641A2 Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
| 08/27/2009 | WO2009105621A1 Androgen receptot-ablative agents |
| 08/27/2009 | WO2009105617A1 Method of treating body insect infestation |
| 08/27/2009 | WO2009105568A1 Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
| 08/27/2009 | WO2009105534A2 Ophthalmic nsaids as adjuvants |
| 08/27/2009 | WO2009105522A1 Methods of making low molecular weight heparin compositions |
| 08/27/2009 | WO2009105513A2 Novel compounds and methods for therapy |
| 08/27/2009 | WO2009105510A1 Methods for using rapamycin analogues in the treatment of neurological disorders |
| 08/27/2009 | WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/27/2009 | WO2009105507A2 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
| 08/27/2009 | WO2009105504A2 Functionally selective alpha2c adrenoreceptor agonists |
| 08/27/2009 | WO2009105500A1 Compounds that are erk inhibitors |
| 08/27/2009 | WO2009105498A1 Anilinopyridines as inhibitors of fak |
| 08/27/2009 | WO2009105484A2 Anti-infective catheters |
| 08/27/2009 | WO2009105440A1 Beta-lactams for reducing intraocular pressure |
| 08/27/2009 | WO2009105438A1 Therapeutic substituted lactams |
| 08/27/2009 | WO2009105435A1 Inhibitors of the chemokine receptor cxcr3 |
| 08/27/2009 | WO2009105430A1 Treating cancer with desthiazolyl ritonavir |
| 08/27/2009 | WO2009105348A1 Imidazobenzazepine cgrp receptor antagonists |
| 08/27/2009 | WO2009105284A1 Methods of preparation of macrocyclic compounds |
| 08/27/2009 | WO2009105283A1 Use of immunogenic compositions for the treatment or prevention of pathogen infections |
| 08/27/2009 | WO2009105265A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 08/27/2009 | WO2009105257A1 Compounds for treating proliferative disorders |
| 08/27/2009 | WO2009105256A2 Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand |
| 08/27/2009 | WO2009105238A2 Kinase protein binding inhibitors |
| 08/27/2009 | WO2009105234A2 Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
| 08/27/2009 | WO2009105230A2 Methods for treating cancer using combination therapy |
| 08/27/2009 | WO2009105220A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
| 08/27/2009 | WO2009105218A2 Propiophenone derivatives |
| 08/27/2009 | WO2009105209A1 Silica nanoparticles postloaded with photosensitizers for drug delivery in photodynamic therapy |
| 08/27/2009 | WO2009105206A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/27/2009 | WO2009105165A2 Cardioplegia solution for cardiac surgery |
| 08/27/2009 | WO2009105164A2 Blood substitute solution |
| 08/27/2009 | WO2009105162A2 Methods and compounds for treatment or prevention of substance-related disorders |
| 08/27/2009 | WO2009105140A2 Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| 08/27/2009 | WO2009105123A1 Compounds, compositions and methods for treating or preventing diseases |
| 08/27/2009 | WO2009105049A1 Oral tablet compositions containing nateglinide and surfactan ph adjusting agent |
| 08/27/2009 | WO2009105026A1 Compound (r) -n*6*-ethyl-6, 7-dihydro-5h-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics |
| 08/27/2009 | WO2009105023A1 Pharmaceutical formulation comprising oxabispidines / 236 |
| 08/27/2009 | WO2009104990A1 2,4-diaminopyridine derivatives, a pharmaceutical composition and a medicinal agent which are based thereon and used for treating or preventing diseases and disturbances caused by the hyperactivation of nmda-receptors and/or in the form of cognitive function stimulators and a method for the use thereof |
| 08/27/2009 | WO2009104988A1 Pharmacological adjuvants based on coordination compounds of d-metals |
| 08/27/2009 | WO2009104963A1 Methods and compositions of sphingolipid for preventing and treating microbial infections |
| 08/27/2009 | WO2009104920A1 Acid salt of tolterodine having effective stability for transdermal drug delivery system |
| 08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | WO2009104807A1 Composition for modulating stem cell growth with prostaglandins |
| 08/27/2009 | WO2009104802A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 08/27/2009 | WO2009104794A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification |
| 08/27/2009 | WO2009104761A1 Anti-viral agents, anti-viral fibers and anti-viral fiber structures |
| 08/27/2009 | WO2009104739A1 Solid preparation for oral administration |
| 08/27/2009 | WO2009104729A1 Amide derivative and pharmaceutical composition containing the same |
| 08/27/2009 | WO2009104696A1 Oral or enteral composition useful for recovery of physical functions |
| 08/27/2009 | WO2009104649A1 Synthetic glycolipid-containing liposomes |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009104248A1 Adrenomedullin production enhancer |